PRODUCT MONOGRAPH METADOL
... Opioids, such as METADOL, should be used with particular care in patients with a history of alcohol and illicit/ prescription drug abuse. However, concerns about abuse, addiction, and diversion should not prevent the proper management of pain. Cardiovascular Hypotensive Effect: The administration o ...
... Opioids, such as METADOL, should be used with particular care in patients with a history of alcohol and illicit/ prescription drug abuse. However, concerns about abuse, addiction, and diversion should not prevent the proper management of pain. Cardiovascular Hypotensive Effect: The administration o ...
Manual on rehabilitation and recovery of drug users
... people with drug dependences, young people with drug use and other behavioral disorders, women at risk of social exclusion, inmigrant population supporting the socio-economic integration of immigrants and their families facing the risk of poverty and social exclusion. Chapter 4 describes Basta, a Sw ...
... people with drug dependences, young people with drug use and other behavioral disorders, women at risk of social exclusion, inmigrant population supporting the socio-economic integration of immigrants and their families facing the risk of poverty and social exclusion. Chapter 4 describes Basta, a Sw ...
A review of the evidence for carbamazepine and oxcarbazepine in
... and the prevention of future episodes. Mood stabilizers are currently the basis of most treatment regimens. Lithium is the classical mood stabilizer (its action was first noted by Cade in 1949), and there is good evidence suggesting that it prevents relapse and recurrence long term. In addition, pati ...
... and the prevention of future episodes. Mood stabilizers are currently the basis of most treatment regimens. Lithium is the classical mood stabilizer (its action was first noted by Cade in 1949), and there is good evidence suggesting that it prevents relapse and recurrence long term. In addition, pati ...
Antiseizure drugs
... • fewer side effects, decreased drug-drug interactions, better compliance, lower costs • Addition of a second drug is likely to result in significant improvement in only approx. 10 % of patients. ...
... • fewer side effects, decreased drug-drug interactions, better compliance, lower costs • Addition of a second drug is likely to result in significant improvement in only approx. 10 % of patients. ...
... Most commonly reported side effects include fatigue, headache, somnolence, dry mouth, gastrointestinal disorders such as nausea, gastritis, and also allergic symptoms like rash. During the marketing of LORATADINE (CLARITIN*) products, alopecia, anaphylaxis, abnormal hepatic function, tachycardia, pa ...
Ritalin LA
... Sudden death, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardio ...
... Sudden death, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardio ...
Percocet® (oxycodone hydrochloride 5 mg / acetaminophen 325 mg)
... tranquilizers, sedative-hypnotics, tricyclic antidepressants, antipsychotics, antihistamines, benzodiazepines, centrally-active anti-emetics and other CNS depressants. Respiratory depression, hypotension and profound sedation, coma or death may result. Observational studies have demonstrated that co ...
... tranquilizers, sedative-hypnotics, tricyclic antidepressants, antipsychotics, antihistamines, benzodiazepines, centrally-active anti-emetics and other CNS depressants. Respiratory depression, hypotension and profound sedation, coma or death may result. Observational studies have demonstrated that co ...
morphine
... • The time of onset, intensity and duration of abstinence syndrome depend on the drug used and its halflife. • With morphine and heroin, withdrawal signs usually start 6-10 hours after the last dose, peaks in 36-48 hours, and most of the effects gradually disappear by the 5th day. ...
... • The time of onset, intensity and duration of abstinence syndrome depend on the drug used and its halflife. • With morphine and heroin, withdrawal signs usually start 6-10 hours after the last dose, peaks in 36-48 hours, and most of the effects gradually disappear by the 5th day. ...
Impurities: Guideline for Residual Solvents
... formulation process has reduced the relevant solvent level to within the acceptable amount. Drug product should also be tested if a solvent is used during its manufacture. This guideline does not apply to potential new drug substances, excipients, or drug products used during the clinical research s ...
... formulation process has reduced the relevant solvent level to within the acceptable amount. Drug product should also be tested if a solvent is used during its manufacture. This guideline does not apply to potential new drug substances, excipients, or drug products used during the clinical research s ...
A - amphetamine
... BJs - crack BLACK - cannabis resin BLACK ACID - LSD and PCP BLACK AND WHITE - amphetamine or ecstasy BLACK BEAUTIES - depressant BLACK BEAUTIES - amphetamine BLACK BIRDS - amphetamine BLACK BOMBERS - amphetamine BLACK CADILLACS - amphetamine BLACK DUST - PCP BLACK GANGA - marijuana resin BLACK GOLD ...
... BJs - crack BLACK - cannabis resin BLACK ACID - LSD and PCP BLACK AND WHITE - amphetamine or ecstasy BLACK BEAUTIES - depressant BLACK BEAUTIES - amphetamine BLACK BIRDS - amphetamine BLACK BOMBERS - amphetamine BLACK CADILLACS - amphetamine BLACK DUST - PCP BLACK GANGA - marijuana resin BLACK GOLD ...
AROPAX® PRODUCT INFORMATION (paroxetine)
... duration of sleep. Moreover, patients are likely to experience improved sleep as they respond to paroxetine therapy. Where it is clinical practice to co-prescribe short-acting hypnotics with antidepressants, no additional adverse events have been recorded. AROPAX, in addition to its significant anti ...
... duration of sleep. Moreover, patients are likely to experience improved sleep as they respond to paroxetine therapy. Where it is clinical practice to co-prescribe short-acting hypnotics with antidepressants, no additional adverse events have been recorded. AROPAX, in addition to its significant anti ...
xanax xanax ts
... expectation) about two or more life circumstances, for a period of six months or longer, during which the person has been bothered more days than not by these concerns. At least 6 of the following 18 symptoms are often present in these patients: Motor Tension (trembling, twitching, or feeling shaky; ...
... expectation) about two or more life circumstances, for a period of six months or longer, during which the person has been bothered more days than not by these concerns. At least 6 of the following 18 symptoms are often present in these patients: Motor Tension (trembling, twitching, or feeling shaky; ...
Solubility enhancement technique for an anti-malarial
... Atovaquone is an Anti-malarial agent and is used in the treatment of malarial complications as chemoprophylaxis. The present research work is focused with an aim to increase solubility and hence dissolution rate of Atovaquone by using the various techniques of preparation of solid dispersion. The po ...
... Atovaquone is an Anti-malarial agent and is used in the treatment of malarial complications as chemoprophylaxis. The present research work is focused with an aim to increase solubility and hence dissolution rate of Atovaquone by using the various techniques of preparation of solid dispersion. The po ...
DICETEL PM
... stomach pain and/or fullness, abdominal pain, nausea, vomiting, difficulty swallowing, constipation, heartburn, bloating or diarrhea. Since these side effects are similar to the symptoms of IBS, it may be hard to tell the difference. Other side effects include headache, dryness of the mouth, drowsin ...
... stomach pain and/or fullness, abdominal pain, nausea, vomiting, difficulty swallowing, constipation, heartburn, bloating or diarrhea. Since these side effects are similar to the symptoms of IBS, it may be hard to tell the difference. Other side effects include headache, dryness of the mouth, drowsin ...
Ritalin LA - Novartis Pharmaceuticals Corporation
... Sudden death, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardio ...
... Sudden death, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardio ...
Treatment of Giardiasis
... while taking metronidazole. The inhibition of aldehyde dehydrogenase by metronidazole can cause severe vomiting, flushing, headache, and gastrointestinal pain following alcohol ingestion. Metronidazole is mutagenic in bacteria and carcinogenic in mice and rats at high doses over long periods (34, 15 ...
... while taking metronidazole. The inhibition of aldehyde dehydrogenase by metronidazole can cause severe vomiting, flushing, headache, and gastrointestinal pain following alcohol ingestion. Metronidazole is mutagenic in bacteria and carcinogenic in mice and rats at high doses over long periods (34, 15 ...
THE ROLE OF CYP3A4/5 IN ALPRAZOLAM METABOLISM
... It is well known that patients may respond differently to the same drug therapy. These inter-individual variations can result in drug toxicity in some patients, while others will experience therapeutic failure. The existence of large population differences with small intra-patient variability is con ...
... It is well known that patients may respond differently to the same drug therapy. These inter-individual variations can result in drug toxicity in some patients, while others will experience therapeutic failure. The existence of large population differences with small intra-patient variability is con ...
Public Assessment Report Mutual Recognition Procedure DALSAN
... The dosage should be set individually depending on nature and severity of the disease, as well as on the patient’s condition and age. The tablets should be taken as a whole, without chewing them, with a small volume of water once daily. Concomitant food intake does not influence the efficacy. Treatm ...
... The dosage should be set individually depending on nature and severity of the disease, as well as on the patient’s condition and age. The tablets should be taken as a whole, without chewing them, with a small volume of water once daily. Concomitant food intake does not influence the efficacy. Treatm ...
Acute coronary syndrome secondary to methylphenidate overdose
... reported in patients with co-ingestion of methylphenidate and ethanol. In contrast to cocaethylene which is a potent cardiotoxic compound formed by cocaineethanol metabolic transesterification in humans,11 the clinical significance and toxicity of ethylphenidate are unknown. The presence of ethylphe ...
... reported in patients with co-ingestion of methylphenidate and ethanol. In contrast to cocaethylene which is a potent cardiotoxic compound formed by cocaineethanol metabolic transesterification in humans,11 the clinical significance and toxicity of ethylphenidate are unknown. The presence of ethylphe ...
Association between KEGG Biological Pathways and Adverse Drug
... metagenomics, metabolomics and other omics studies, modeling and simulation in systems biology, and translational research in drug development. The KEGG database started in 1995 by Professor Minoru Kanehisa at the Institute for Chemical Research, Kyoto University [6]. KEGG Pathway mapping is the pro ...
... metagenomics, metabolomics and other omics studies, modeling and simulation in systems biology, and translational research in drug development. The KEGG database started in 1995 by Professor Minoru Kanehisa at the Institute for Chemical Research, Kyoto University [6]. KEGG Pathway mapping is the pro ...
File
... uses, and their side effects. • Know why and how lithium and other drugs are used in treating bipolar disorders. • Be familiar with antipsychotics and the drugs that prevent their side effects. • Define anxiety, learn its symptoms, and know the drugs used in its treatment. • Recognize the course and ...
... uses, and their side effects. • Know why and how lithium and other drugs are used in treating bipolar disorders. • Be familiar with antipsychotics and the drugs that prevent their side effects. • Define anxiety, learn its symptoms, and know the drugs used in its treatment. • Recognize the course and ...
Sustained release microspheres of ropinirole hydrochloride: Effect of
... be satisfactory in preventing agglomeration during the stirring process, which resulted in increased production yield (Table III) as well as in obtaining perfectly smooth spherical microspheres (Fig. 1a). DCM was initially employed as polar internal organic solvent phase for preparation of microsphe ...
... be satisfactory in preventing agglomeration during the stirring process, which resulted in increased production yield (Table III) as well as in obtaining perfectly smooth spherical microspheres (Fig. 1a). DCM was initially employed as polar internal organic solvent phase for preparation of microsphe ...
Pharmacological approach to smoking cessation J. REVIEW
... withdrawal symptoms appearing when the cerebral nicotine level is falling (negative reinforcement) [9). In most smokers, both behavioural and pharmacological determinants are interactive, and their relative strength can vary from smoker to smoker and, in the same subject, can vary with Lime, the cen ...
... withdrawal symptoms appearing when the cerebral nicotine level is falling (negative reinforcement) [9). In most smokers, both behavioural and pharmacological determinants are interactive, and their relative strength can vary from smoker to smoker and, in the same subject, can vary with Lime, the cen ...
Polysubstance dependence
A person with polysubstance dependence is psychologically addicted to being in an intoxicated state without a preference for one particular substance. Although any combination of three drugs can be used, studies have shown that alcohol is commonly used with another substance. This is supported by one study on polysubstance use that separated participants who used multiple substances into groups based on their preferred drug. The three substances were cocaine, alcohol, and heroin, which implies that those three are very popular. Other studies have found that opiates, cannabis, amphetamines, hallucinogens, inhalants and benzodiazepines are often used in combination as well. The results of a long-term or longitudinal study on substance use led the researchers to observe that excessively using or relying on one drug increased the probability of excessively using or relying on another drug.